China National Medicines Corporation Ltd.
600511
Rangering i aksjer
#4963
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aksjekurs
$3.90
Markedsverdi
$2.94B
Endring (1 dag)
-1.46%
Endring (1 år)
-3.02%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)
Kategori
Healthcare
Inntekter for China National Medicines Corporation Ltd. (600511)
Inntekter i Jun 2026 TTM: $364.66M
Ifølge China National Medicines Corporation Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $364.66M. I 2023 hadde selskapet et resultat på $414.05M, en økning sammenlignet med resultatet i 2022, som var $389.67M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for China National Medicines Corporation Ltd. fra 2000 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $364.66M | 0.30% |
| 2024 | $363.55M | -12.20% |
| 2023 | $414.05M | 6.26% |
| 2022 | $389.67M | 1.30% |
| 2021 | $384.65M | 31.06% |
| 2020 | $293.50M | -15.78% |
| 2019 | $348.48M | 18.48% |
| 2018 | $294.13M | 9.94% |
| 2017 | $267.54M | 18.23% |
| 2016 | $226.29M | 120.07% |
| 2015 | $102.83M | 1.91% |
| 2014 | $100.90M | 15.95% |
| 2013 | $87.02M | 28.00% |
| 2012 | $67.98M | 4.71% |
| 2011 | $64.92M | 26.10% |
| 2010 | $51.48M | 19.05% |
| 2009 | $43.24M | 17.69% |
| 2008 | $36.75M | 38.38% |
| 2007 | $26.56M | 79.82% |
| 2006 | $14.77M | 65.07% |
| 2005 | $8.95M | 30.75% |
| 2004 | $6.84M | 4.66% |
| 2003 | $6.54M | 21.97% |
| 2002 | $5.36M | 27.10% |
| 2001 | $4.22M | 35.00% |
| 2000 | $3.12M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $6.46B | 1,670.97% |
US
|
|
| - | - |
US
|
|
| $2.17B | 496.17% |
US
|
|
| - | - |
US
|
|
| $708.86M | 94.39% |
AU
|
